Ireland
--:--IST
Latest
Clinical Trials in Australia / NCT06867380
Active, not recruiting Not applicable

An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant Recipients

NCT06867380 · tracked via the Priya Life Science Australia tracker
Sponsor
Phase
Not applicable
Started
2025-05-27
Last updated
2026-03-09

Condition(s) studied

Cochlear Implant RecipientsHearing Loss, Cochlear

Investigational drug(s) / intervention(s)

Investigational sound coding strategyCochlear default sound coding strategy

Investigational sound coding strategy: SPARC (Stimulation Place and Rate Coding) sound coding strategies

Cochlear default sound coding strategy: ACE (Advanced Combination Encoder) sound coding strategy

Study summary

This study will evaluate a range of experimental sound coding strategies that may improve hearing for cochlear implant recipients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Users of an approved Nucleus cochlear implant. * Aged 18 years or older (no upper age limit). * Open set speech understanding sufficient to complete the study protocol as judged by the investigator. * Fluent speaker in the language used to assess speech perception performance, as determined by the investigator. * Willing and able to provide written informed consent. Exclusion Criteria: * Unable or unwilling to comply with the requirements of the clinical investigation as determined by the investigator. * Additional health factors, known to the investigator, that would prevent or restrict participation in the audiological evaluations. * Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. * Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation * Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation).

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
HEARnet Clinical studies Carlton Victoria
Cochlear Melbourne East Melbourne Victoria

More Cochlear trials in Australia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06867380 on ClinicalTrials.gov ↗ ← All trials in Australia